Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00104338
What this trial is testing

Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy

Who this might be right for
BK PolyomavirusKidney Diseases
Astellas Pharma Inc 45
Early research (Phase 1)Study completedNCT00095108
What this trial is testing

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Who this might be right for
MelanomaKidney NeoplasmsMetastases
ZymoGenetics 43
Early research (Phase 1)Looking for participantsNCT06805825
What this trial is testing

The c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Who this might be right for
Gastrointestinal Stromal TumorsSmall-cell Lung CancerAdenoid Cystic Carcinoma+4 more
Novelty Nobility, Inc. 67
Early research (Phase 1)Study completedNCT02852876
What this trial is testing

Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

Who this might be right for
Herpes GenitalisHerpes Zoster
Astellas Pharma Europe Ltd. 72
Early research (Phase 1)Study completedNCT04354246
What this trial is testing

COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Who this might be right for
Advanced CancerOvarian CancerLung Cancer+6 more
Compugen Ltd 94
Early research (Phase 1)Active Not RecruitingNCT07038369
What this trial is testing

ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Who this might be right for
Advanced Solid TumorsBreast CancerBreast Carcinoma+24 more
Atavistik Bio, Inc 134
Early research (Phase 1)UnknownNCT04768868
What this trial is testing

The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Impact Therapeutics, Inc. 350
Not applicableLooking for participantsNCT05449691
What this trial is testing

Biological Matrices Versus Synthetic Meshes

Who this might be right for
Breast Cancer
University Hospitals of Derby and Burton NHS Foundation Trust 60
Early research (Phase 1)Study completedNCT05673603
What this trial is testing

Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Who this might be right for
Renal Impairment
Insmed Incorporated 28
Early research (Phase 1)Ended earlyNCT06034860
What this trial is testing

Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

Who this might be right for
Non Small Cell Lung CancerHepatocellular CarcinomaMelanoma+8 more
Molecular Templates, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00703196
What this trial is testing

Folic Acid Clinical Trial for the Prevention of Cervical Cancer

Who this might be right for
Cervical CancerPrecancerous Condition
University of Alabama at Birmingham 368
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Early research (Phase 1)UnknownNCT06118827
What this trial is testing

HS-10518 in Healthy Female Participants

Who this might be right for
Endometriosis
Jiangsu Hansoh Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Study completedNCT02681861
What this trial is testing

Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects

Who this might be right for
Healthy SubjectsPharmacokinetics of ASP6294
Astellas Pharma Europe B.V. 74
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Post-approval studies (Phase 4)Study completedNCT00365170
What this trial is testing

Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 419
Early research (Phase 1)Study completedNCT04680273
What this trial is testing

Study to Investigate the Absorption, Metabolism, and Excretion of [14C]-GDC-9545 Following a Single Oral Dose (Part 1) and to Evaluate the Absolute and Relative Bioavailability of Oral Capsule Formulations of GDC-9545 (Part 2) in Healthy Female Subjects of Non-Childbearing Potential

Who this might be right for
Healthy Volunteers
Genentech, Inc. 16
Not applicableStudy completedNCT03509454
What this trial is testing

PeRsOnalising Treatment Of Diabetic Nephropathy:

Who this might be right for
Diabetes Mellitus, Type 1Diabetes ComplicationsDiabetic Nephropathies
Peter Rossing 210
Early research (Phase 1)Ended earlyNCT06714617
What this trial is testing

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Who this might be right for
Breast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more
SystImmune Inc. 3
Not applicableStudy completedNCT04141891
What this trial is testing

Advancing Understanding of Transportation Options

Who this might be right for
Diabetic RetinopathyMacular DegenerationGlaucoma+29 more
University of Colorado, Denver 529
Next Page